PharmaMar is a fully integrated Spanish biotech/pharmaceutical. Born in 1986, the company takes its inspiration for discovery of oncology medicines from the sea.
We are inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. We intend to continue to be the world leader in marine medicinal discovery, development and innovation.
90% of all drugs entering clinical trials fail to gain approval. With a first approval in 2007, and a third drug approved by 2020, our hypothesis and platform technology have been validated. To get 3 drugs approved is something under 1% of biotech companies achieve. We are in the 1%.
AV/ de los Reyes 1, 28770 Colmenar – Spain
Nov. 13, 2015Stock exchange(s)
Bolsa de Madrid